- Patent Title: Diarylalkylamine REV-ERB antagonists and their use as medicaments
-
Application No.: US15359135Application Date: 2016-11-22
-
Publication No.: US09949968B2Publication Date: 2018-04-24
- Inventor: Benedetto Grimaldi , Esther Torrente , Rita Scarpelli , Giovanni Bottegoni , Tiziano Bandiera , Marina Veronesi
- Applicant: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
- Applicant Address: IT Genoa
- Assignee: Fondazione Istituto Italiano Di Tecnologia
- Current Assignee: Fondazione Istituto Italiano Di Tecnologia
- Current Assignee Address: IT Genoa
- Agency: Seed IP Law Group LLP
- Priority: ITTO2013A0816 20131009
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/495 ; A61K31/4453 ; A61K31/445
Abstract:
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: It further discloses a pharmaceutical composition comprising the compounds of Formula (I) and their uses as anti-proliferative and proapoptotic agents for cancer therapy.
Public/Granted literature
- US20170136009A1 DIARYLALKYLAMINE REV-ERB ANTAGONISTS AND THEIR USE AS MEDICAMENTS Public/Granted day:2017-05-18
Information query
IPC分类:
